Clinical AI leader Abridge Raises $150M in Series C Investment

Abridge Digital Solutions News

Abridge, the leader in generative AI for clinical documentation, recently announced a significant $150M investment through a Series C funding. This investment marks one of the largest funding rounds ever made for generative AI for health care.

Abridge plans to use this funding to support improvements to existing product lines and continue to develop new ways to personalize notes, integrate more deeply into electronic medical record (EMR) systems, and provide clinicians with after-visit insights. 

UPMC Enterprises continues to support Abridge as part of our portfolio, showcasing our commitment to next-generation health care and innovation through technology.

Read the Abridge press release and their featured articles to learn more:

You Might Also Like…

More From the Blog